» Articles » PMID: 37335403

Effect of Resistance Exercise Training on Plasma Neurofilaments in Multiple Sclerosis: a Proof of Concept for Future Designs

Overview
Journal Neurol Sci
Specialty Neurology
Date 2023 Jun 19
PMID 37335403
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is a dysimmune and neurodegenerative disease of the central nervous system that continues to be one of the main causes of non-traumatic disability in young people despite the recent availability of highly effective drugs. Exercise-based interventions seem to have a positive impact on the course of the disease although pathophysiological mechanisms responsible for this benefit remain unclear. This is a longitudinal study to examine the effects of a short-term training program on neurofilament plasma levels, a biomarker of axonal destruction, measured using the ultrasensitive single molecule array (SiMoA). Eleven patients completed a 6-week supervised resistance-training program of 18 sessions that consisted of 3 sets of 8-10 repetitions of 7 exercises. Median plasma neurofilament levels significantly decreased from baseline (6.61 pg/ml) to 1 week after training intervention (4.44 pg/ml), and this effect was maintained after 4 weeks of detraining (4.38 pg/ml). These results suggest a neuroprotective effect of resistance training in this population and encourage us to investigate further the beneficial impact of physical exercise and to emphasize the importance of lifestyle in MS.

Citing Articles

Effects of Physical Exercise on Neurofilament Light Chain and Glial Fibrillary Acidic Protein Level in Patients with Multiple Sclerosis: A Systematic Review and Bayesian Network Meta-Analysis.

Blazquez-Fernandez A, Navarro-Lopez V, Marcos-Anton S, Cano-de-la-Cuerda R J Clin Med. 2025; 14(3).

PMID: 39941510 PMC: 11818769. DOI: 10.3390/jcm14030839.


Pumping up the Fight against Multiple Sclerosis: The Effects of High-Intensity Resistance Training on Functional Capacity, Muscle Mass, and Axonal Damage.

Maroto-Izquierdo S, Mulero P, Menendez H, Pinto-Fraga J, Lista S, Santos-Lozano A Healthcare (Basel). 2024; 12(8).

PMID: 38667599 PMC: 11050496. DOI: 10.3390/healthcare12080837.

References
1.
Vukusic S, Confavreux C . Natural history of multiple sclerosis: risk factors and prognostic indicators. Curr Opin Neurol. 2007; 20(3):269-74. DOI: 10.1097/WCO.0b013e32812583ad. View

2.
Valenzuela P, Castillo-Garcia A, Morales J, de la Villa P, Hampel H, Emanuele E . Exercise benefits on Alzheimer's disease: State-of-the-science. Ageing Res Rev. 2020; 62:101108. DOI: 10.1016/j.arr.2020.101108. View

3.
Kjolhede T, Vissing K, Dalgas U . Multiple sclerosis and progressive resistance training: a systematic review. Mult Scler. 2012; 18(9):1215-28. DOI: 10.1177/1352458512437418. View

4.
Joisten N, Rademacher A, Warnke C, Proschinger S, Schenk A, Walzik D . Exercise Diminishes Plasma Neurofilament Light Chain and Reroutes the Kynurenine Pathway in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021; 8(3). PMC: 8054957. DOI: 10.1212/NXI.0000000000000982. View

5.
Thompson A, Banwell B, Barkhof F, Carroll W, Coetzee T, Comi G . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017; 17(2):162-173. DOI: 10.1016/S1474-4422(17)30470-2. View